The short answer
Biomarker testing looks for specific changes in a tumor. Those results can qualify a person for trials of treatments designed to target that exact change.
Biomarkers are measurable features of a tumor, often genetic changes.
Biomarker testing can reveal targets for specific treatments.
Many modern trials require a particular biomarker to join.
Testing can be done on tumor tissue or sometimes blood.
Choose how you want to understand this
The full explanation.
What a biomarker is
A biomarker is a measurable feature of a tumor — often a specific genetic change or protein. Biomarkers can help diagnose a cancer, predict how it may behave, and, importantly, point to treatments designed to target that exact feature.
The link to trials
Many modern cancer trials enroll only people whose tumors carry a particular biomarker, because the treatment being studied is built to target that change. In other words, the test result can be the key that unlocks a trial. Without it, you may not know a matching study exists.
How the testing works
Biomarker testing is usually done on a sample of tumor tissue taken during a biopsy or surgery. In some situations, a blood test — sometimes called a liquid biopsy — can detect certain markers without another tissue sample.
A question worth asking
If you are exploring clinical trials, ask your oncologist whether your tumor has had biomarker or genetic testing, and whether the results match any open trials. Sometimes additional testing reveals options that were not visible before.
Words to know
Tap any term to see what it means.
Common questions
▸What is a biomarker?
A biomarker is a measurable feature of a tumor — often a specific gene change or protein — that can guide diagnosis, predict behavior, or point to a treatment that targets it.
▸How does testing connect to trials?
Many newer trials enroll only people whose tumors carry a particular biomarker, because the treatment is designed to target that exact change. Testing shows whether you match.
▸How is biomarker testing done?
It is usually done on a sample of tumor tissue from a biopsy or surgery. In some cases, a blood test (sometimes called a liquid biopsy) can detect certain markers.
▸Should I ask about it?
If you are exploring trials, it is reasonable to ask your oncologist whether biomarker testing has been done and whether the results open any trial options.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Test your knowledge
0 of 5 answered
This quiz checks understanding of educational content only. It is not medical advice. Open this quiz on its own page.
How this page was created
Cancer Explained uses AI to organize and translate information from the authoritative sources cited on each page. Automated checks review claims, citations, clarity, duplication, and potential safety concerns before publication. Our content is not currently reviewed by physicians unless a specific qualified reviewer is named on the page. Cancer Explained provides general education and should not replace advice from your healthcare team.
Human medical review: not completed. At this time, most Cancer Explained content has not been reviewed by a physician or other healthcare professional. Pages with documented human medical review identify the reviewer, credentials, and review date directly.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.